Company profile: Formation Bio
1.1 - Company Overview
Company description
- Provider of a drug development platform and AI-driven tools to accelerate and optimize clinical trials and drug discovery. Offerings include an end-to-end platform leveraging proprietary technology, a clinical trial engine to improve recruitment, data collection and monitoring, and a universal data platform centralizing clinical data for rapid application creation and trial design.
Products and services
- Clinical Trial Engine: An automation-enabled tech platform that accelerates clinical trials by improving patient recruitment, streamlining data collection, and enhancing trial monitoring through integrated data analysis
- Drug Development Platform: An end-to-end technology platform that develops drugs more efficiently, enhancing value per program and speeding patient access to new treatments using proprietary capabilities
- Universal Data Platform: A centralized repository that organizes and assimilates diverse clinical data sources to support rapid application creation and streamlined clinical trial design.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Formation Bio
Arlington Medical Resources
HQ: United States
Website
- Description: Provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arlington Medical Resources company profile →
Insife
HQ: Denmark
Website
- Description: Provider of life science consulting and drug safety technology, offering HALOPV, an integrated platform for end-to-end pharmacovigilance (case intake, processing, regulatory compliance); HALOPV Enterprise for large-scale cloud environments; GRIP, a global regulatory intelligence subscription; an AI case intake solution; and a PSMF module that automates Pharmacovigilance System Master Files.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insife company profile →
Lixoft
HQ: France
Website
- Description: Provider of modeling and simulation software for advanced model-based drug development, offering solutions for population analysis in pre-clinical and clinical trials and for treatment individualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lixoft company profile →
Marken
HQ: United States
Website
- Description: Provider of patient-centric clinical trial logistics for the pharmaceutical and life sciences industries, including clinical trial sample delivery, chain of custody shipping, global control center monitoring, real-time clinical shipment tracking, vaccine trial storage, and a home healthcare management system; maintains a leading position in Direct to Patient services and biological sample shipments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marken company profile →
ClinPhone
HQ: United Kingdom
Website
- Description: Provider of clinical technology, headquartered in Nottingham, United Kingdom, offering ClinPhone RTSM, part of the Perceptive MyTrials eClinical platform, for randomization and trial supply management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinPhone company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Formation Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Formation Bio
2.2 - Growth funds investing in similar companies to Formation Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Formation Bio
4.2 - Public trading comparable groups for Formation Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →